U.S. FDA approves ScPharmaceuticals' heart failure therapy

Published: Monday, October 10, 2022 at 2:43 pm

The U.S. Food and Drug Administration on Monday approved ScPharmaceuticals Inc's therapy for patients with chronic heart failure.

Full Coverage